Skip to content
Review Open access

Next-generation nanobiosensors enable dynamic, real-time glucose monitoring for precision diabetes therapy

Aug 2026 · Discover Sensors · Vol 2 · 1 citation · 129 references

TL;DR

This review critically summarises recent developments in nanomaterial-enabled glucose biosensors, compares emerging sensing platforms and their analytical performance, discusses current challenges, and highlights future translational opportunities for developing clinically applicable, patient-friendly, and precision medicine-oriented glucose monitoring technologies.

Abstract

Diabetes mellitus is a rapidly growing global health challenge characterized by chronic hyperglycemia resulting from impaired insulin secretion, insulin action, or both. Achieving optimal glycemic control requires continuous, accurate, and real-time glucose monitoring to minimize acute and long-term complications. Conventional glucose monitoring technologies, particularly enzyme-based electrochemical biosensors, have significantly improved diabetes management; however, their widespread clinical application remains limited by enzyme instability, oxygen dependence, biofouling, limited long-term stability, frequent calibration requirements, and restricted performance in complex physiological environments. These limitations have accelerated the development of next-generation nanobiosensors that integrate advanced nanomaterials, including gold nanoparticles, carbon nanotubes, graphene, MXenes, and metal oxides, to enhance sensitivity, selectivity, electron-transfer efficiency, biocompatibility, and operational stability. Furthermore, wearable and minimally invasive biosensing platforms capable of monitoring glucose in sweat, saliva, tears, and interstitial fluid have emerged as promising alternatives, improving patient compliance while supporting continuous glucose monitoring. Recent advances in wireless communication, artificial intelligence, machine learning, and Internet of Things-enabled healthcare have furthered personalised diabetes management through predictive analytics and closed-loop insulin delivery systems. Despite these advances, important challenges remain, including large-scale manufacturing, clinical validation, regulatory approval, standardisation, long-term reliability, and cost-effective commercialization. This review critically summarises recent developments in nanomaterial-enabled glucose biosensors, compares emerging sensing platforms and their analytical performance, discusses current challenges, and highlights future translational opportunities for developing clinically applicable, patient-friendly, and precision medicine-oriented glucose monitoring technologies.

Read PDF

Similar papers

Review Open access Aug 2026

Glucose-Responsive Nanomedicine in Diabetes Therapy: Emerging Advances and Clinical Prospects

Diabetes mellitus continues to impose a substantial global health burden, underscoring the need for therapeutic systems capable of achieving precise, adaptive, and patient-friendly glycemic control. Conventional diabetes treatments, including repeated insulin injections and oral hypoglycemic agents, are often constrain...

Adnan Alsaei, Ayah Binrajab, Shahd Alsaei et al. · 0 citations
Review Open access Sep 2026

The Evolution of Next-Generation Glucose Monitoring Systems: Developments from Conventional Diagnostics to Wearable and Continuous Sensing Platforms—A Narrative Review

For the diagnosis of diabetes, glycemic control, treatment modification, and the avoidance of both acute and long-term consequences, accurate glucose monitoring is crucial. This study examines the development of glucose-monitoring systems, from traditional diagnostic tests and finger-prick electrochemical glucometers t...

S. Prabhu · 0 citations
Review Open access Oct 2026

Microneedle Based Platforms for Glucose Monitoring: Current Status and Future Directions.

All the recent advancements in microneedle-based biosensors have made them a new emerging platform for next-generation personalized medicine, along with a digital healthcare system.

V. Sujan, Jobin Jose, Prachi Dwivedi et al. · 0 citations
Review Open access Sep 2026

Metal–organic framework-based wearable electrochemical glucose sensors for sweat analysis: materials design, sensing mechanisms, and future perspectives

This review critically examines recent advances in MOF-enabled wearable electrochemical glucose sensors, with emphasis on material design principles, enzymatic and non-enzymatic sensing mechanisms, device integration strategies, and key performance metrics.

P. Krishnamoorthy, A. Rajendran · 0 citations
#artificial intelligence Review Open access Sep 2026

Nanostructure driven innovation in diabetes: from enhanced biosensing to smart therapeutic delivery

Diabetes mellitus continues to be a global public health concern, owing to its increasing incidence, complex etiology, and the limitations of standard therapy regimens. Conventional therapeutic strategies often face several limitations including poor bioavailability, frequent administration, and absence of real-time bl...

T. Yousaf, I. Ahmad, Z. Younas et al. · 0 citations
Review Open access Sep 2026

Nanomaterial -enabled flexible sensors for continuous biomedical monitoring and closed-loop intervention

This comprehensive overview provides a structured reference for the application of flexible nanomaterials in health monitoring, disease management, and clinical translation, underscoring the promising trajectory of flexible sensing toward intelligent, real-time medical intervention.

Yue Zeng, Si-Zhu Hou, Chen-Yu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.